$5.30
-0.07-1.3%
Last update: Nov 9, 4:26 PM
Cumberland Pharmaceuticals Inc
CPIXNASDAQ
Cumberland Pharmaceuticals rose 171.2% from $1.98 to $5.37, ahead of the S&P 500's +10.0%. Its worst day was Oct 26 (−48.8%), and its low came Nov 17 at $1.90.
Nov 10, 2025 – Nov 9, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Cumberland Pharmaceuticals closed at its lowest level of the year, 4.0% below where the year started.
−10.0% · S&P 500 −0.9%
Cumberland Pharmaceuticals shares rose 20.2%, while the S&P 500 fell 0.3%.
Story events cover the past 12 months · Times ET
+20.2% · S&P 500 −0.3%
Cumberland Pharmaceuticals shares rose 18.0%, while the S&P 500 rose 0.6%.
+18.0% · S&P 500 +0.6%
EPS of $-0.01 was reported on $13.7M revenue.
−19.9% · S&P 500 +0.7%
Cumberland Pharmaceuticals shares rose 27.9%, while the S&P 500 fell 0.4%.
+27.9%, on 52M shares, the year's heaviest volume · S&P 500 −0.4%
EPS of $-0.13 was reported on $9.1M revenue.
−4.0% · S&P 500 +1.4%
EPS of $-0.20 was reported on $166,458.00 revenue.
−2.8% · S&P 500 −0.2%
Cumberland Pharmaceuticals closed at its highest level of the year, 353.0% above where the year started.
+3.1% · S&P 500 0.0%
Cumberland Pharmaceuticals shares fell 48.8%, while the S&P 500 rose 0.7%.
−48.8%, the year's worst day · S&P 500 +0.7%
Where it ended: a close of $5.37 on Nov 9, 2026. Up next: Q3 2026 earnings on Nov 10, 2026.
Nothing in the past 12 months.
All CPIX analyst actionsNothing in the past 12 months.
All CPIX dividend historyChart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for CPIX and SPY from Benzinga historical bars. Not investment advice.
